PERSPECTIV™ is the first commercially available panel capable of interrogating blood (serum or plasma) protein glycosylation across thousands of peptides and glycopeptides - hypothesis-free or targeted. This high-throughput panel empowers translational researchers to identify new biomarkers or discover new insights.
PERSPECTIV™ is also capable of:
Glyco-as-a-Complement to existing DNA/RNA assays
Enabling development of diagnostic assays
Discovering new novel glycoproteomic biomarkers
Additionally, InterVenn is open to discuss sponsorship opportunities for Investigator Initiated Studies (IIS).